News Blow for MSD as NICE rejects Keytruda in first line lung can... Firm will have to offer further discount to get drug to NHS patients.
News NICE rejects second Alexion ultra-rare disease drug NHS will not fund Kanuma for rare disease LAL-D.
News Digital heart scan can save NHS millions HeartFlow could save NHS England a minimum of around £9.1 million by 2022.
News AZ's Tagrisso gets NHS funding in Scotland SMC backs drug based on feedback from patients and doctors, after rejection by NICE.
News Incyte’s leukaemia drug Iclusig recommended by NICE Leukaemia drug latest to move out of Cancer Drugs Fund
News Andexxa reaches the end of the line in the US AstraZeneca will voluntarily take its anticoagulant reversal agent Andexxa off the market in the US amid reports of serious clotting side effects.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
